Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 21.29% is 11206% above its 5-year average of 0.19%, near the high end of its 5-year range (0.00%–22.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 137.45% above its 12-month average of 8.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 21.29%.
DEBT TO ASSETS RATIO
21.29%
DEBT TO ASSETS RATIO AVG TTM
8.97%
DEBT TO ASSETS RATIO AVG 3Y
0.29%
DEBT TO ASSETS RATIO AVG 5Y
0.19%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+137.45%
CURRENT VS 3Y AVG
+7329.98%
CURRENT VS 5Y AVG
+11205.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
+23556.46%
vs the sector median at left
Hyperfine, Inc.
Market Cap
$76.69M
Debt to Assets Ratio
21.29%
TTM Avg
8.97%
3Y Avg
0.29%
5Y Avg
0.19%
Market Cap
$75.91M
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.53M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.31M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.35M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.11M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.88M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $76.69M | 21.29% | 8.97% | 0.29% | 0.19% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.91M | 0.75% | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.53M | 0.03% | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $75.71M | 0.43% | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | 0.06% | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $78.35M | 0.49% | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.11M | 0.16% | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $80.88M | 0.09% | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $81.36M | 0.03% | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.66M | 0.04% | N/A | N/A | N/A |
Debt/Assets
21.3%
Debt/Equity
0.36
Current Ratio
6.15
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 21.29% |
| 2026-03-31 | 22.13% |
| 2025-12-31 | 0.45% |
| 2025-09-30 | 0.44% |
| 2025-06-30 | 0.53% |
| 2025-03-31 | 0.49% |
| 2024-12-31 | 0.46% |
| 2024-09-30 | 0.16% |
| 2024-06-30 | 0.21% |
| 2024-03-31 | 0.22% |
| 2023-12-31 | 0.20% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.22% |
| 2021-06-30 | 0.21% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.25% |
